
Melody M. Burch
Examiner (ID: 12874, Phone: (571)272-7114 , Office: P/3657 )
| Most Active Art Unit | 3657 |
| Art Unit(s) | 3683, 3657, 3616, 3613 |
| Total Applications | 1593 |
| Issued Applications | 935 |
| Pending Applications | 131 |
| Abandoned Applications | 553 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5732206
[patent_doc_number] => 20060257323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Preventing insufflation and injection modes of drug abuse'
[patent_app_type] => utility
[patent_app_number] => 11/406886
[patent_app_country] => US
[patent_app_date] => 2006-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2914
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257323.pdf
[firstpage_image] =>[orig_patent_app_number] => 11406886
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/406886 | Preventing insufflation and injection modes of drug abuse | Apr 18, 2006 | Abandoned |
Array
(
[id] => 5569429
[patent_doc_number] => 20090252807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'Nanoparticulate and Controlled Release Compositions Comprising Prostaglandin Derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/568698
[patent_app_country] => US
[patent_app_date] => 2006-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17423
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20090252807.pdf
[firstpage_image] =>[orig_patent_app_number] => 11568698
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/568698 | Nanoparticulate and Controlled Release Compositions Comprising Prostaglandin Derivatives | Apr 12, 2006 | Abandoned |
Array
(
[id] => 5732349
[patent_doc_number] => 20060257466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Administration of macrophage targeted formulations of compounds which modulate cholesterol-metabolizing enzymes for treatment of atherosclerosis'
[patent_app_type] => utility
[patent_app_number] => 11/399066
[patent_app_country] => US
[patent_app_date] => 2006-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5603
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257466.pdf
[firstpage_image] =>[orig_patent_app_number] => 11399066
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/399066 | Administration of macrophage targeted formulations of compounds which modulate cholesterol-metabolizing enzymes for treatment of atherosclerosis | Apr 5, 2006 | Abandoned |
Array
(
[id] => 5857763
[patent_doc_number] => 20060228307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Structures and methods for delivering topical compositions'
[patent_app_type] => utility
[patent_app_number] => 11/397300
[patent_app_country] => US
[patent_app_date] => 2006-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1371
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20060228307.pdf
[firstpage_image] =>[orig_patent_app_number] => 11397300
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/397300 | Structures and methods for delivering topical compositions | Apr 3, 2006 | Abandoned |
Array
(
[id] => 5834303
[patent_doc_number] => 20060246133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same'
[patent_app_type] => utility
[patent_app_number] => 11/396420
[patent_app_country] => US
[patent_app_date] => 2006-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14051
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246133.pdf
[firstpage_image] =>[orig_patent_app_number] => 11396420
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/396420 | Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same | Mar 30, 2006 | Abandoned |
Array
(
[id] => 5677454
[patent_doc_number] => 20060182809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'System for transporting active substances in a biological system'
[patent_app_type] => utility
[patent_app_number] => 11/308484
[patent_app_country] => US
[patent_app_date] => 2006-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6141
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20060182809.pdf
[firstpage_image] =>[orig_patent_app_number] => 11308484
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/308484 | System for transporting active substances in a biological system | Mar 28, 2006 | Abandoned |
Array
(
[id] => 5264487
[patent_doc_number] => 20090117172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'ORAL DELIVERY VEHICLE AND MATERIAL'
[patent_app_type] => utility
[patent_app_number] => 11/909848
[patent_app_country] => US
[patent_app_date] => 2006-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8873
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20090117172.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909848
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909848 | ORAL DELIVERY VEHICLE AND MATERIAL | Mar 27, 2006 | Abandoned |
Array
(
[id] => 4976776
[patent_doc_number] => 20070218007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Ophthalmic visualization compositions and methods of using same'
[patent_app_type] => utility
[patent_app_number] => 11/378506
[patent_app_country] => US
[patent_app_date] => 2006-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7594
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20070218007.pdf
[firstpage_image] =>[orig_patent_app_number] => 11378506
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/378506 | Ophthalmic visualization compositions and methods of using same | Mar 16, 2006 | Abandoned |
Array
(
[id] => 4879382
[patent_doc_number] => 20080152765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-26
[patent_title] => 'Coated Granular Formulations'
[patent_app_type] => utility
[patent_app_number] => 11/817848
[patent_app_country] => US
[patent_app_date] => 2006-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4248
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20080152765.pdf
[firstpage_image] =>[orig_patent_app_number] => 11817848
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/817848 | Coated Granular Formulations | Mar 14, 2006 | Abandoned |
Array
(
[id] => 5858032
[patent_doc_number] => 20060228413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Controlled release venlafaxine formulations'
[patent_app_type] => utility
[patent_app_number] => 11/363845
[patent_app_country] => US
[patent_app_date] => 2006-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 22286
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20060228413.pdf
[firstpage_image] =>[orig_patent_app_number] => 11363845
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/363845 | Controlled release venlafaxine formulations | Feb 27, 2006 | Abandoned |
Array
(
[id] => 5704864
[patent_doc_number] => 20060193912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Controlled release O-desmethylvenlafaxine formulations'
[patent_app_type] => utility
[patent_app_number] => 11/363842
[patent_app_country] => US
[patent_app_date] => 2006-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12930
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20060193912.pdf
[firstpage_image] =>[orig_patent_app_number] => 11363842
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/363842 | Controlled release O-desmethylvenlafaxine formulations | Feb 27, 2006 | Abandoned |
Array
(
[id] => 5648418
[patent_doc_number] => 20060134150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Submicron suspensions with polymorph control'
[patent_app_type] => utility
[patent_app_number] => 11/283397
[patent_app_country] => US
[patent_app_date] => 2006-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12857
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134150.pdf
[firstpage_image] =>[orig_patent_app_number] => 11283397
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/283397 | Submicron suspensions with polymorph control | Feb 26, 2006 | Abandoned |
Array
(
[id] => 5732387
[patent_doc_number] => 20060257504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'COMPOSITIONS FOR THE PREPARATION OF CARBON DIOXIDE GEL FOR EXTERNAL USE AND CARBON DIOXIDE GELS FOR EXTERNAL USE'
[patent_app_type] => utility
[patent_app_number] => 11/307710
[patent_app_country] => US
[patent_app_date] => 2006-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27398
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257504.pdf
[firstpage_image] =>[orig_patent_app_number] => 11307710
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/307710 | COMPOSITIONS FOR THE PREPARATION OF CARBON DIOXIDE GEL FOR EXTERNAL USE AND CARBON DIOXIDE GELS FOR EXTERNAL USE | Feb 16, 2006 | Abandoned |
Array
(
[id] => 5704734
[patent_doc_number] => 20060193782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Abuse-proofed dosage form'
[patent_app_type] => utility
[patent_app_number] => 11/349537
[patent_app_country] => US
[patent_app_date] => 2006-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11923
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20060193782.pdf
[firstpage_image] =>[orig_patent_app_number] => 11349537
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/349537 | Abuse-proofed dosage form | Feb 5, 2006 | Abandoned |
Array
(
[id] => 5297573
[patent_doc_number] => 20090012499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'NOVEL METHOD FOR TREATING CHRONIC SEVERE HEART FAILURE BY USING INSULIN-LIKE GROWTH FACTOR-1 (IGF-1)'
[patent_app_type] => utility
[patent_app_number] => 11/815684
[patent_app_country] => US
[patent_app_date] => 2006-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7857
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012499.pdf
[firstpage_image] =>[orig_patent_app_number] => 11815684
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/815684 | NOVEL METHOD FOR TREATING CHRONIC SEVERE HEART FAILURE BY USING INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) | Feb 5, 2006 | Abandoned |
Array
(
[id] => 5677441
[patent_doc_number] => 20060182796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Taste masked pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 11/346700
[patent_app_country] => US
[patent_app_date] => 2006-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5708
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20060182796.pdf
[firstpage_image] =>[orig_patent_app_number] => 11346700
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/346700 | Taste masked pharmaceutical compositions | Feb 2, 2006 | Abandoned |
Array
(
[id] => 5616146
[patent_doc_number] => 20060185678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Devices for delivering agents to a vaginal tract'
[patent_app_type] => utility
[patent_app_number] => 11/346560
[patent_app_country] => US
[patent_app_date] => 2006-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5561
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 37
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20060185678.pdf
[firstpage_image] =>[orig_patent_app_number] => 11346560
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/346560 | Devices for delivering agents to a vaginal tract | Feb 2, 2006 | Abandoned |
Array
(
[id] => 8006201
[patent_doc_number] => 08084501
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-27
[patent_title] => 'Stable prostaglandin-containing compositions'
[patent_app_type] => utility
[patent_app_number] => 11/336115
[patent_app_country] => US
[patent_app_date] => 2006-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6565
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/084/08084501.pdf
[firstpage_image] =>[orig_patent_app_number] => 11336115
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/336115 | Stable prostaglandin-containing compositions | Jan 19, 2006 | Issued |
Array
(
[id] => 5759682
[patent_doc_number] => 20060210627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Direct compression formulation and process'
[patent_app_type] => utility
[patent_app_number] => 11/333582
[patent_app_country] => US
[patent_app_date] => 2006-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 27164
[patent_no_of_claims] => 127
[patent_no_of_ind_claims] => 106
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20060210627.pdf
[firstpage_image] =>[orig_patent_app_number] => 11333582
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/333582 | Direct compression formulation and process | Jan 16, 2006 | Abandoned |
Array
(
[id] => 5219329
[patent_doc_number] => 20070160640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'Halofuginone delivering vascular medical devices'
[patent_app_type] => utility
[patent_app_number] => 11/330448
[patent_app_country] => US
[patent_app_date] => 2006-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4736
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20070160640.pdf
[firstpage_image] =>[orig_patent_app_number] => 11330448
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/330448 | Halofuginone delivering vascular medical devices | Jan 11, 2006 | Abandoned |